Archive for the ‘Long Term Care’ Category

Proposed drug policy changes put sick Canadians at risk, patient advocate warns

February 22, 2018

Implications for patients with rare medical diseases if the Canadian Government follows through with the patented drug pricing policy review and makes changes to the current policy. Many Canadians who rely on having access to medications for rare diseases will be affected by the changes as it will make the drugs more difficult to obtain for these patients. Canada already lags behind several other countries in accessing these rare medications.

Read More